"Development of nucleic acid drugs leading to osteoporosis and cancer treatment"
Lecturer Kaori Yasuda, Professor Yasuhiro Isogai, and Special Professor
Toshiyuki Sakaki of the Department of Pharmaceutical Engineering at Toyama
Prefectural University in collaboration with a research group from Kanazawa
University and Bio Seeds Corporation published a paper in ACS Applied Materials
& Interfaces in April, 2022, claiming to have successfully obtained
nucleic acid molecules that selectively inhibit CYP24A1.
【Kitanippon Shinbun dated JUNE 4th, 2022】 